Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vivos Therapeutics Inc
(NQ:
VVOS
)
2.240
-0.010 (-0.44%)
Streaming Delayed Price
Updated: 10:01 AM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vivos Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Report on Q2 2024 Financial Results, Operational Update
August 15, 2024
Via
Investor Brand Network
VVOS Stock Earnings: Vivos Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 14, 2024
VVOS stock results show that Vivos Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Plans Release of Q2 2024 Financial Results, Conference Call
August 14, 2024
Via
Investor Brand Network
TinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Reports Results of Seven-Month Provider-Based Marketing and Distribution Model Pilot
June 27, 2024
Via
Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Strategic Alliance, Private Equity Investment
June 12, 2024
Via
Investor Brand Network
Exposures
Product Safety
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q1 2024 Financial Report, Operational Update
May 15, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 15, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 15, 2024
We are covering the biggest pre-market stock movers for Wednesday with all of the latest happenings worth watching this morning!
Via
InvestorPlace
VVOS Stock Earnings: Vivos Therapeutics Reported Results for Q1 2024
May 14, 2024
Vivos Therapeutics just reported results for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 14, 2024
Via
Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Schedules Release of Q1 2024 Results, Conference Call
May 14, 2024
Via
Investor Brand Network
TinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) CEO Discusses Medicare Reimbursement Approval for CARE Oral Medical Devices in Proactive Interview
April 10, 2024
Via
Investor Brand Network
Topics
Product Recall
Exposures
Legal
Product Safety
TinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Achieves Milestone with CARE Oral Medical Devices Gaining Approval for Medicare Reimbursement
April 09, 2024
Via
Investor Brand Network
What's Going On With Vivos Therapeutics Stock?
April 09, 2024
Vivos Therapeutics shares are trading lower Tuesday. The company filed a prospectus related to the resale of up to 1.73 million shares of common stock by selling shareholders. Vivos said that if the...
Via
Benzinga
Why Is Laser Photonics (LASE) Stock Up 130% Today?
April 09, 2024
Laser Photonics stock is rising higher on Tuesday as LASE investors celebrate a new unit order from L3Harris Technologies.
Via
InvestorPlace
Why Is Vivos Therapeutics (VVOS) Stock Up 16% Today?
April 09, 2024
Vivos Therapeutics stock is up on Tuesday as VVOS investors react to the company securing full Medicare reimbursement for its OSA device.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 09, 2024
Pre-market stock movers are worth checking out as we get into all of the hottest news investors need to know about on Tuesday morning!
Via
InvestorPlace
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
April 01, 2024
Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 01, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 01, 2024
It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
March 29, 2024
Via
Benzinga
VVOS Stock Earnings: Vivos Therapeutics Misses EPS, Misses Revenue for Q4 2023
March 28, 2024
VVOS stock results show that Vivos Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
March 28, 2024
Via
Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Schedules Release of Q4 and FY 2023 Results, Conference Call
March 28, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 15, 2024
Via
Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Exercise of Warrants for ~$4M
February 15, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 15, 2024
Via
Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) CEO Highlights Favorable Market Developments Creating New Opportunities
February 13, 2024
Via
Investor Brand Network
Topics
Product Recall
Exposures
Legal
Product Safety
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Notes Key Market Developments Resulting in Growth Opportunities
February 06, 2024
Via
Investor Brand Network
Topics
Product Recall
Exposures
Legal
Product Safety
12 Health Care Stocks Moving In Monday's Intraday Session
January 29, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.